Skip to main content
Erschienen in: Journal of Gastroenterology 7/2018

08.11.2017 | Original Article—Liver, Pancreas, and Biliary Tract

A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort

verfasst von: Yutaka Suzuki, Toshiyuki Mori, Masaaki Yokoyama, Sangchul Kim, Hirokazu Momose, Ryota Matsuki, Masaharu Kogure, Nobutsugu Abe, Hiroyuki Isayama, Takahiro Nakazawa, Kenji Notohara, Atsushi Tanaka, Toshio Tsuyuguchi, Susumu Tazuma, Hajime Takikawa, Masanori Sugiyama

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatolithiasis frequently results in severe complications. We conducted a cohort study to identify prognostic factors and to establish a hepatolithiasis severity classification system.

Methods

The study cohort comprised 396 patients who were identified through a 1998 nationwide survey and followed up for 18 years or until death. Cox regression analysis was used to identify prognostic factors.

Results

Median survival time of the patients was 308 (range 0–462) months. Of the 396 patients enrolled in the study, 118 (29.8%) died, most frequently from intrahepatic cholangiocarcinoma (25 patients, 21.2%). Age of ≥ 65 years at the time of initial diagnosis [hazard ratio (HR) 3.410], jaundice for ≥ 1 week during follow-up (HR 2.442), intrahepatic cholangiocarcinoma (HR 3.674), and liver cirrhosis (HR 5.061) were shown to be significant risk factors for death from any therapeutic course. The data led to a 3-grade disease severity classification system that incorporates intrahepatic cholangiocarcinoma and liver cirrhosis as major factors and age of ≥ 65 years and jaundice for ≥ 1 week during follow-up as minor factors. Survival rates differed significantly between grades.

Conclusions

The proposed hepatolithiasis severity classification system can be used to assess prognosis and thereby improve patient outcomes.
Literatur
1.
Zurück zum Zitat Tazuma S, Unno M, Igarashi Y, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52:276–300.CrossRefPubMed Tazuma S, Unno M, Igarashi Y, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52:276–300.CrossRefPubMed
2.
Zurück zum Zitat Suzuki Y, Mori T, Abe N, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined since Japanese multicenter study. Hepatol Res. 2012;42:166–70.CrossRefPubMed Suzuki Y, Mori T, Abe N, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined since Japanese multicenter study. Hepatol Res. 2012;42:166–70.CrossRefPubMed
3.
Zurück zum Zitat Suzuki Y, Mori T, Yokoyama M, et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci. 2014;21:617–22.CrossRefPubMed Suzuki Y, Mori T, Yokoyama M, et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci. 2014;21:617–22.CrossRefPubMed
4.
Zurück zum Zitat Ohta T, Nagakawa T, Ueda N, et al. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer. 1991;68:2217–23.CrossRefPubMed Ohta T, Nagakawa T, Ueda N, et al. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer. 1991;68:2217–23.CrossRefPubMed
5.
Zurück zum Zitat Chijiiwa K, Ichimiya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet. 1993;177:279–82.PubMed Chijiiwa K, Ichimiya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet. 1993;177:279–82.PubMed
6.
Zurück zum Zitat Chijiiwa K, Yamashita H, Yoshida J, et al. Current management and long-term prognosis of hepatolithiasis. Arch Surg. 1995;130:194–7.CrossRefPubMed Chijiiwa K, Yamashita H, Yoshida J, et al. Current management and long-term prognosis of hepatolithiasis. Arch Surg. 1995;130:194–7.CrossRefPubMed
7.
Zurück zum Zitat Kubo S, Kinoshita H, Hirohashi K, et al. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995;19:637–41.CrossRefPubMed Kubo S, Kinoshita H, Hirohashi K, et al. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995;19:637–41.CrossRefPubMed
8.
Zurück zum Zitat Chijiiwa K, Ohtani K, Noshiro H, et al. Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis. Hepatogastroenterology. 2002;49:96–9.PubMed Chijiiwa K, Ohtani K, Noshiro H, et al. Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis. Hepatogastroenterology. 2002;49:96–9.PubMed
9.
10.
Zurück zum Zitat Tabrizian P, Jibara G, Shrager B, et al. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–6.CrossRefPubMed Tabrizian P, Jibara G, Shrager B, et al. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–6.CrossRefPubMed
11.
Zurück zum Zitat Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma risk as long-term outcome after hepatic resection in the hepatolithiasis patients. World J Surg. 2015;39:1537–42.CrossRefPubMed Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma risk as long-term outcome after hepatic resection in the hepatolithiasis patients. World J Surg. 2015;39:1537–42.CrossRefPubMed
12.
Zurück zum Zitat Isa T, Kusano T, Shimoji H, et al. Predictive factors for long-term survival in patients intrahepatic cholangiocarcinoma. Am J Surg. 2001;181:507–11.CrossRefPubMed Isa T, Kusano T, Shimoji H, et al. Predictive factors for long-term survival in patients intrahepatic cholangiocarcinoma. Am J Surg. 2001;181:507–11.CrossRefPubMed
13.
Zurück zum Zitat Jeng KS, Shih SC, Chiang HJ, et al. Secondary biliary cirrhosis. A limiting factors in the treatment of hepatolithiasis. Arch Surg. 1989;124:1301–5.CrossRefPubMed Jeng KS, Shih SC, Chiang HJ, et al. Secondary biliary cirrhosis. A limiting factors in the treatment of hepatolithiasis. Arch Surg. 1989;124:1301–5.CrossRefPubMed
14.
Zurück zum Zitat Pu Q, Zhang C, Zhang C, et al. Choledochoscopic lithotripsy is a useful adjunct to laparoscopic common bile duct exploration for hepatolithiasis: a cohort study. Am J Surg. 2016;211:1058–63.CrossRefPubMed Pu Q, Zhang C, Zhang C, et al. Choledochoscopic lithotripsy is a useful adjunct to laparoscopic common bile duct exploration for hepatolithiasis: a cohort study. Am J Surg. 2016;211:1058–63.CrossRefPubMed
15.
Zurück zum Zitat Park JS, Jeong S, Lee DH, et al. Risk factors for long-term outcomes after initial treatment in hepatolithiasis. J Korean Med Sci. 2013;28:1627–31.CrossRefPubMedPubMedCentral Park JS, Jeong S, Lee DH, et al. Risk factors for long-term outcomes after initial treatment in hepatolithiasis. J Korean Med Sci. 2013;28:1627–31.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kurumaya H, Terada T, Nakanuma Y. ‘Metaplastic lesions’ in intrahepatic bile ducts in hepatolithiasis: a histochemical and immunohistochemical study. J Gastroenterol Hepatol. 1990;5:530–6.CrossRefPubMed Kurumaya H, Terada T, Nakanuma Y. ‘Metaplastic lesions’ in intrahepatic bile ducts in hepatolithiasis: a histochemical and immunohistochemical study. J Gastroenterol Hepatol. 1990;5:530–6.CrossRefPubMed
17.
Zurück zum Zitat Sato Y, Sasaki M, Harada K, et al. Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraductal neoplasia. J Gastroenterol. 2014;49:64–72.CrossRefPubMed Sato Y, Sasaki M, Harada K, et al. Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraductal neoplasia. J Gastroenterol. 2014;49:64–72.CrossRefPubMed
Metadaten
Titel
A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort
verfasst von
Yutaka Suzuki
Toshiyuki Mori
Masaaki Yokoyama
Sangchul Kim
Hirokazu Momose
Ryota Matsuki
Masaharu Kogure
Nobutsugu Abe
Hiroyuki Isayama
Takahiro Nakazawa
Kenji Notohara
Atsushi Tanaka
Toshio Tsuyuguchi
Susumu Tazuma
Hajime Takikawa
Masanori Sugiyama
Publikationsdatum
08.11.2017
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2018
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1410-6

Weitere Artikel der Ausgabe 7/2018

Journal of Gastroenterology 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.